In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
All content for The Analytical Wavelength is the property of ACD/Labs and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
Season 3 Trailer and Bonus Episode: N-Nitrosmaines, Is the Worst Over?
The Analytical Wavelength
30 minutes
3 years ago
Season 3 Trailer and Bonus Episode: N-Nitrosmaines, Is the Worst Over?
Our experts at ACD/Labs spend their days working with the best and brightest in the pharmaceutical and chemical industries. For season 3 of the Analytical Wavelength, we wanted to feature members of our team so they could share their unique perspectives on the trends and science and technology. Look forward to new episodes starting in September.Until then, we wanted to share something extra for our loyal listeners. In February 2022, AstraZeneca’s Dr. Andrew Teasdale presented at the ACD/Labs ...
The Analytical Wavelength
In this episode, ACD/Labs Vice President of Innovation and Informatics Strategy, Andrew Anderson, and Strategic Partnerships Director, Graham McGibbon continue their discussion on digitalization and digital transformation in the context of pharmaceutical R&D. They assess how well the industry is adapting to the current digital landscape, and what can be done to contribute to the overall digitalization process.Andrew and Graham also share their thoughts on how digitalization can be used al...
